CCO Management Series
Psychiatric Disorders in HIV-Infected Patients
Diagnosis and Treatment of Psychiatric Disorders in HIV-Infected Patients |
Module 1 of 2 |
|
Program Director: Glenn J. Treisman, MD, PhD
|
|
In this comprehensive module, Stephen J. Ferrando, MD, outlines current understanding of psychiatric comorbidities in HIV-infected patients and treatment for each disorder.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the prevalence of psychiatric disorders in HIV-infected patients
- Explain various assessment tools for psychiatric disorders in HIV-infected patients
- Describe treatment approaches for psychiatric disorders in HIV-infected patients
|
Impact of Psychiatric Disorders on HIV Management |
Module 2 of 2 |
|
Program Director: Glenn J. Treisman, MD, PhD
- Ian Everall, FRCPath, FRCPsych, PhD
|
|
|
Ian Everall, FRCPath, FRCPsych, PhD, discusses the clinical management of HIV-infected individuals with mental illnesses such as major depressive disorder, anxiety disorders, psychotic disorders, and substance abuse.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Summarize the clinical data concerning the increased risk of HIV infection among patients with psychiatric disorders
- Discuss the most common psychiatric disorders observed in HIV-infected patients
- Describe the potential impact of psychiatric disorders on HIV treatment goals
|
Interactive Case Challenges
Initiating Therapy in a Patient With Substance Abuse Disorder
|
Program Chair: Glenn J. Treisman, MD, PhD
|
|
Andrew Angelino, MD, guides the participant through the decisions that might be faced when starting antiretroviral medications in a patient with a chaotic lifestyle and substance addiction.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Outline the principles that guide the choice of substance abuse treatment
- Describe how drug abuse therapy may evolve with the patient’s changing circumstances
- Discuss how drug abuse therapy becomes integrated with treatment for HIV infection
|
Managing Therapy in a Patient With Increasing Anxiety
|
Program Director: Glenn J. Treisman, MD, PhD
|
|
Stephen J. Ferrando, MD, describes management of a young HIV-infected woman with posttraumatic stress disorder.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Outline the differential diagnosis for anxiety disorders
- Discuss the prevalence of anxiety disorders such as in HIV-infected populations and how that differs from the general population
- List various treatment options for anxiety in HIV-infected patients, particularly addressing the promises and pitfalls of benzodiazepines
|
Managing Adherence in a Patient With Multiple Medical Disorders and an Affective Disorder
|
Program Director: Glenn J. Treisman, MD, PhD
|
|
Mary Alice O’Dowd, MD, guides the participant through a case involving a middle-aged patient with multiple medical disorders who must manage her antiretroviral medications, her other essential medications, and treatment for an affective disorder.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify appropriate initial medication strategies for affective disorders
- Describe when dose escalation is appropriate
- Discuss how affective disorders may affect antiretroviral adherence in HIV-infected patients
|
CCO Slideset
Psychiatric Disorders in HIV-Infected Patients
 |
|
Glenn J. Treisman, MD, PhD, presents data that illustrate how psychiatric disorders affect the management of HIV-infected patients.
Format: Microsoft PowerPoint (.ppt) |
File size: 1.37 MB
|
Disclaimer: The materials published on the Clinical Care Options
Web site reflect the views of the reviewers or authors of the
CCO
material, not those of Clinical Care Options, LLC, the CME provider,
or the companies providing educational grants. The materials may
discuss uses and dosages for therapeutic products that have not been
approved by the United States Food and Drug Administration. A qualified
healthcare professional should be consulted before using any therapeutic
product discussed. Readers should verify all information and data before
treating patients or using any therapies described in these materials.
|
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
Contact Info
Educational grant provided by:
Educational grants support only the CME-certified components of this program.
|